MRA 2017-2018 Request for Proposals

Special Opportunity for Acral Melanoma Research

The Melanoma Research Alliance (MRA) announces a Special Opportunity Request for Proposals (RFP) soliciting high-impact research that will lead to therapeutic targeting of acral melanoma. Priority will be given to proposals that focus on NF1 loss, TERT promoter alterations, CCND1 and/or CRKL amplification. Research leading to therapeutic interventions and/or improved understanding of how these genetic alterations contribute to acral melanoma development and progression will be considered. Acral melanoma need not be the sole focus of the research, however, priority will be given to proposals that incorporate acral melanoma in at least one specific aim.

Proposals will be accepted for Young Investigator Awards and Team Science Awards.

December 15, 2017: Deadline for Team Science Award proposal title, technical abstract and list of team members

December 15, 2017: Deadline for Young Investigator Award proposal title, technical abstract and confirmation of eligibility

January 9, 2018: Deadline for Team Science Award and Young Investigator full-length proposals

Full descriptions of each award opportunity offered, as well as eligibility criteria and instructions can be found in the MRA 2017-2018 Special Opportunity for Acral Melanoma Research RFP document:

MRA 2017-2018 Special Opportunity for Acral Melanoma Research Request for Proposals

MRA Award Terms and Conditions 

Questions: 

Tasheema Prince, MRA Scientific Program Manager  

tprince@curemelanoma.org


MRA 2017-2018 Request for Proposals

The Melanoma Research Alliance (MRA) announces a Request for Proposals (RFP) soliciting high-impact pre-clinical, translational, and early clinical research from scientists and clinicians around the world. The RFP calls for ideas that have the potential to lead to near-term clinical application in melanoma prevention, detection, diagnosis, staging, and treatment.

Proposals will be accepted for Young Investigator Awards, Team Science Awards, and Academic-Industry Partnership Awards (for Established Investigators). Please note that two Special Opportunities are available: 

  • Special Opportunity Women in Scientific Research Young Investigator Award
  • Rising Tide Foundation for Clinical Cancer Research (RTFCCR)-MRA Team Science Award for European-led Teams

October 6, 2017: Deadline for Team Science Award Letters of Intent including the RTFCCR-MRA European-led Team Science Award

November 17, 2017: Deadline for Young Investigator Award and Academic Industry-Partnership Award proposals

January 9, 2018: Deadline for meritorious Team Science Award full-length proposals

Full descriptions of each award opportunity offered, including the just-announced Special Opportunity Award for European-led Teams, as well as eligibility criteria and instructions can be found in the Second Release MRA 2017-2018 RFP document:

Second Release MRA 2017-2018 Request for Proposals

MRA Award Terms and Conditions 

Questions: 

Tasheema Prince, MRA Scientific Program Manager  

tprince@curemelanoma.org

About Melanoma

Melanoma is a leading cause of new cancers, and more effective options for patients and those at risk are urgently needed. Recent scientific and clinical advances have provided new hope, but much work remains to be done to end suffering and death from melanoma.

Login

×